sitagliptin glp 1 agonist GLP-1 receptor agonists or DPP-4 inhibitors: How to guide the clinician? GLP-1 and the kidney: from
Description
New approaches for the treatment of Alzheimers disease
& Morimoto, C
Acta Pharm Sin B 11 , 24492468
Comparative efficacy of pharmacologic therapies for MASH in reducing liver fat content: systematic review and network meta-analysis
STUDIES ON THE PHYSIOLOGY OF SECRETIN: III
In the market, a large number of teams are developing therapeutic drugs targeting GLP-1R, GIPR, and GCGR
